Clarus Therapeutics Holdings, Inc. - FORM S-1 - EX-99.5 - CONSENT OF ALLAN L. SHAW. - September 2, 2020

Attached files

file filename
EX-99.2 - FORM OF COMPENSATION COMMITTEE CHARTER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-2_bluewater.htm
EX-99.6 - CONSENT OF MICHAEL LERNER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-6_bluewater.htm
EX-99.4 - CONSENT OF KIM MURPHY. - Clarus Therapeutics Holdings, Inc.fs12020ex99-4_bluewater.htm
EX-99.3 - CONSENT OF JAMES SAPIRSTEIN. - Clarus Therapeutics Holdings, Inc.fs12020ex99-3_bluewater.htm
EX-99.1 - FORM OF AUDIT COMMITTEE CHARTER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-1_bluewater.htm
EX-23.1 - CONSENT OF MARCUM LLP.T - Clarus Therapeutics Holdings, Inc.fs12020ex23-1_bluewater.htm
EX-14.1 - FORM OF CODE OF ETHICS. - Clarus Therapeutics Holdings, Inc.fs12020ex14-1_bluewater.htm
EX-10.5 - SECURITIES SUBSCRIPTION AGREEMENT, DATED JUNE 30, 2020, BETWEEN THE REGISTRANT A - Clarus Therapeutics Holdings, Inc.fs12020ex10-5_bluewater.htm
EX-10.1 - PROMISSORY NOTE, DATED JUNE 30, 2020, ISSUED TO JOSEPH HERNANDEZ - Clarus Therapeutics Holdings, Inc.fs12020ex10-1_bluewater.htm
EX-3.3 - BYLAWS - Clarus Therapeutics Holdings, Inc.fs12020ex3-3_bluewater.htm
EX-3.1 - CERTIFICATE OF INCORPORATION. - Clarus Therapeutics Holdings, Inc.fs12020ex3-1_bluewater.htm
S-1 - REGISTRATION STATEMENT ON FORM S-1 - Clarus Therapeutics Holdings, Inc.fs12020_bluewateracq.htm

Exhibit 99.5

 

CONSENT OF YVONNE MCBURNEY

 

Blue Water Acquisition Corp. intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the "Registration Statement"), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement as a Director Nominee.

  

September 2, 2020  /s/ Yvonne McBurney
  Yvonne McBurney